Anesthesia Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Anesthesia Companies and the Market is segmented by Drug Type (General Anesthesia Drugs and Local Anesthesia Drugs), Route of Administration (Inhalation, Injection, and Other Routes of Administration), Application (General Surgery, Cosmetic Surgery, Plastic Surgery, Dental Surgery, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market size and forecasts for Anesthesia Drugs are Provided in value (USD million) for the above segments.

Anesthesia Drugs Market Size

Anesthesia Drugs Market Summary

Anesthesia Drugs Market Analysis

The Global Anesthesia Drugs Market size is estimated at USD 7.51 billion in 2025, and is expected to reach USD 8.87 billion by 2030, at a CAGR of 3.4% during the forecast period (2025-2030).

Due to the emergence of the pandemic situation, demand for anesthesia drugs decreased slightly in 2020, resulting in surgeries being postponed or canceled. According to a study published in the British Journal of Surgery in May 2020, around 28.4 million elective surgeries worldwide were estimated to be canceled or postponed, based on 12 weeks of peak disruption to hospital services due to COVID-19. However, as activities resume, all of the elective surgeries that had been postponed are now being completed, increasing Anesthesia Drugs consumption.

The primary factors propelling the growth of this Anesthesia Drugs Market are the rising number of surgeries and new anesthesia drug approvals. According to the American Society of Plastic Surgeons, in 2020, 2.3 million cosmetic surgical procedures, 13.2 million cosmetic minimally invasive procedures, and 6.8 million reconstructive procedures were performed in the United States, representing a 3% increase over 2019. This indicates the rising number of surgeries, which ultimately results in the rising demand for anesthesia drugs.

Moreover, according to the article 'Trauma of Major Surgery' published in the National Center for Biotechnology Information (NCBI) in July 2020, globally, a staggering 310 million major surgeries are performed each year. Similarly, according to the article titled 'Incidence and Cumulative Risk of Major Surgery in Older Persons in the United States' published in July 2021, in the United States, nearly nine major surgeries were performed annually for every 100 older persons, and more than 1 in 7 Medicare beneficiaries underwent a major surgery over five years, representing nearly 5 million unique older people.

Furthermore, the development and approvals of novel Local Anesthesia Drugs are proving to be a new revenue-generating resource for market players. For instance, in February 2021, PainPass launched the first Cannabidiol (CBD)/lidocaine product line targeting those with chronic pain and for numbing muscles externally, contributing to the growth of the Topical Anesthetics Market. In December 2021, Hikma Pharmaceuticals PLC (Hikma) has launched Bupivacaine HCl Injection, USP through its United States affiliate, Hikma Pharmaceuticals United States Inc. The company has launched 0.25%, 0.5%, and 0.75% in 10mL and 30mL doses. Moreover, in June 2021, PAION AG received United Kingdom Medicines & Healthcare products Regulatory Agency (MHRA) approval for Byfavo (remimazolam besylate) in adults for procedural sedation.

Thus, all aforementioned factors, such as the increasing number of surgical procedures and product launches, boost the market over the forecast period.

Anesthesia Drugs Industry Overview

The Anesthesia Drugs Market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with rising drug approvals, mid-size to smaller companies are expanding their market presence by introducing new ingredients at lower prices. Companies like Baxter, Abbott Laboratories, Aspen, Fresenius SE, Roche, and B. Braun Melsungen AG are among the Top Anesthesia Manufacturers holding substantial market shares in the Anesthesia Drugs Market.

Anesthesia Drugs Market Leaders

  1. Baxter International Inc.

  2. Aspen Pharmacare Holdings Limited

  3. B. Braun Melsungen AG

  4. Fresenius SE & Co. KGaA

  5. Pfizer Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Anesthesia Drugs Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Anesthesia Drugs Market News

  • In January 2022, Laboratoires Théa SAS (Théa) entered an agreement to purchase seven branded ophthalmic products from Akorn Operating Company LLC. The strategic move will enable Théa to add Akorn branded products to its portfolio, including Akten (lidocaine HCl ophthalmic gel), a local anesthetic indicated for ocular surface anesthesia during ophthalmologic procedures.
  • In February 2022, Sedana Medical AB announced the launch of Sedaconda (isoflurane) in Germany. Sedaconda (isoflurane) received European DCP approval in July 2021. Also, the product has received national approvals in 14 countries. Additional applications for marketing approval have been submitted in the same year, and in 2022, the company is expected to receive national approvals in Italy, Poland, Switzerland, and the United Kingdom.

Anesthesia Drugs Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Number of Surgeries
    • 4.2.2 New Approvals of Anesthesia Drugs
    • 4.2.3 Reduction in the Cost of Newly Invented Drugs
  • 4.3 Market Restraints
    • 4.3.1 Side Effects of General Anesthetics
    • 4.3.2 Lack of Skilled Anesthetics
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Drug Type
    • 5.1.1 General Anesthesia Drugs
    • 5.1.1.1 Propofol
    • 5.1.1.2 Sevoflurane
    • 5.1.1.3 Desflurane
    • 5.1.1.4 Dexmedetomidine
    • 5.1.1.5 Remifentanil
    • 5.1.1.6 Midazolam
    • 5.1.1.7 Other General Anesthesia Drugs
    • 5.1.2 Local Anesthesia Drugs
    • 5.1.2.1 Bupivacaine
    • 5.1.2.2 Ropivacaine
    • 5.1.2.3 Lidocaine
    • 5.1.2.4 Chloroprocaine
    • 5.1.2.5 Prilocaine
    • 5.1.2.6 Benzocaine
    • 5.1.2.7 Other Local Anesthesia Drugs
  • 5.2 By Route of Administration
    • 5.2.1 Inhalation
    • 5.2.2 Injection
    • 5.2.3 Other Routes of Administration
  • 5.3 By Application
    • 5.3.1 General Surgery
    • 5.3.2 Plastic Surgery
    • 5.3.3 Cosmetic Surgery
    • 5.3.4 Dental Surgery
    • 5.3.5 Other Applications
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 AbbVie Inc.
    • 6.1.2 Apsen Pharmacare Holdings Limited
    • 6.1.3 Baxter International Inc.
    • 6.1.4 B. Braun Melsungen AG
    • 6.1.5 Fresenius SE & Co. KGaA
    • 6.1.6 Pfizer Inc.
    • 6.1.7 Teva Pharmaceutical Industries Limited
    • 6.1.8 Dr. Reddy's Laboratories
    • 6.1.9 Abbott Laboratories Inc.
    • 6.1.10 Novartis AG
    • 6.1.11 Eisai Inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Anesthesia Drugs Industry Segmentation

As per the scope of the report, anesthesia is a drug that induces a reversible loss of sensation. Anesthesia is one of the essential components of any surgical procedure. It induces temporary unconsciousness and loss of protective reflexes. General anesthesia drugs suppress the activities of the central nervous system and induce a complete lack of sensation. Local anesthetics restrict the transmission of nerve impulses from the targeted region to the spinal cord. The anesthesia drugs market is segmented by drug type (general anesthesia drugs and local anesthesia drugs), route of administration (inhalation, injection, and other routes of administration), application (general surgery, cosmetic surgery, plastic surgery, dental surgery, and other applications), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers market size and forecasts in value (USD million) for the above segments.

By Drug Type General Anesthesia Drugs Propofol
Sevoflurane
Desflurane
Dexmedetomidine
Remifentanil
Midazolam
Other General Anesthesia Drugs
Local Anesthesia Drugs Bupivacaine
Ropivacaine
Lidocaine
Chloroprocaine
Prilocaine
Benzocaine
Other Local Anesthesia Drugs
By Route of Administration Inhalation
Injection
Other Routes of Administration
By Application General Surgery
Plastic Surgery
Cosmetic Surgery
Dental Surgery
Other Applications
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Anesthesia Drugs Market Research FAQs

How big is the Global Anesthesia Drugs Market?

The Global Anesthesia Drugs Market size is expected to reach USD 7.51 billion in 2025 and grow at a CAGR of 3.40% to reach USD 8.87 billion by 2030.

What is the current Global Anesthesia Drugs Market size?

In 2025, the Global Anesthesia Drugs Market size is expected to reach USD 7.51 billion.

Who are the key players in Global Anesthesia Drugs Market?

Baxter International Inc., Aspen Pharmacare Holdings Limited, B. Braun Melsungen AG, Fresenius SE & Co. KGaA and Pfizer Inc. are the major companies operating in the Global Anesthesia Drugs Market.

Which is the fastest growing region in Global Anesthesia Drugs Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Anesthesia Drugs Market?

In 2025, the North America accounts for the largest market share in Global Anesthesia Drugs Market.

What years does this Global Anesthesia Drugs Market cover, and what was the market size in 2024?

In 2024, the Global Anesthesia Drugs Market size was estimated at USD 7.25 billion. The report covers the Global Anesthesia Drugs Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Anesthesia Drugs Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Anesthesia Drugs Industry Report

Statistics for the 2025 Global Anesthesia Drugs market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Anesthesia Drugs analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Anesthesia Drugs Market Report Snapshots

Compare market size and growth of Global Anesthesia Drugs Market with other markets in Healthcare Industry

Anesthesia Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)